Mixlab raises $20M to supply purrfect drug store experience for animal parents

Mixlab raises $20M to supply purrfect drug store experience for animal parents

Animal pharmacy Mixlab has established a digital platform allowing veterinarians to recommend medications and have them provided– often on the very same day– to pet parents. “The pharmacy industry is changing a lot, and technology permits us to customize the care and experience for the veterinarian, animal moms and dad and the pet,” Kim said. Mixlab’s innovation includes a digital service for veterinarians to streamline their everyday medication workflow and provides them back time to spend with patient care. On the family pet parent side, they no longer have to wait up to a week for medications nor have to drive over to the clinic to choose them up. As part of the financial investment, Keith Levy, running partner at Sonoma Brands and former president of family pet food manufacturer Royal Canin U.S.A., will sign up with Mixlab’s board of directors.

Spain’s Savana Medica raises $15 million to bring to the US its AI toolkit turning clinical notes into care insights

Spain’s Savana Medica raises $15 million to bring to the US its AI toolkit turning clinical notes into care insights

Savana, a device learning-based service that turns scientific notes into structured client information for physicians and pharmacists, has actually raised $15 million to take its innovation from Spain to the U.S., the company said. The investment was led by Cathay Development, with involvement from the Spanish financial investment firm Seaya Ventures, which led the business’s previous round, and […]…

Treasure8 includes Chris Cowart to its executive group as it restores pushing its tech to decrease food waste

Treasure8 includes Chris Cowart to its executive group as it restores pushing its tech to decrease food waste

Chris Cowart, the long time IDEO product designer, Singularity University faculty member and specialist to a range of endeavor companies and tech jobs, is joining the food preservation technology designer Treasure8 as its new chief innovation and strategy officer, according to a post on LinkedIn.” In the last 3 years food has come forward […] “In the last 3 years food has actually come to the fore as a style,” said Cowart in an interview with TechCrunch. At X, Cowart was looking at projects that would utilize synthetic intelligence to accelerate circular economy projects and it was there that he started to focus on food waste. The gravity of the circumstance around America’s food waste and food insecurity in the country was driven house through Cowart’s research, he stated. Targeting less than$50 million, the new round could help the business as Cowart starts to believe longer term about ways that Treasure8’s treatment process could contribute to the development of more functional foods. …

Owkin raises $25 million as it constructs a secure network for healthcare analysis and research study

Owkin raises $25 million as it constructs a secure network for healthcare analysis and research study

Envision a design of collaborative research and development among health centers, pharmaceutical companies, universities and other research organizations where no one shared any real data. That’s the dream of the brand-new New York-based start-up Owkin, which has raised $25 million in fresh financing from investors, including Bpifrance Big Endeavor, Cathay Development and MACSF (the French Pension […] In its quest to get more companies and organizations to open up and share information– with the guarantee that the details can’t be extracted or used in a way that isn’t permitted by the owners of the data– Owkin is replicating work that other business are pursuing in fields ranging from healthcare to financial services and beyond. Owkin makes money by allowing remote access to the
data information for pharmaceutical companies business licensing certifying models developed by universities to those companies. The COVID-19 epidemic has stressed the need for closer cooperation among various corporations and research institutions, and that has also increased need for the company’s technology.(COAI), and is utilizing its platform to advance collective research and accelerate scientific advancement of reliable treatments for patients contaminated with the coronavirus, the company stated.